Prelude Capital Management’s Flexion Therapeutics, Inc. FLXN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q4 | – | Sell |
-38,000
| Closed | -$232K | – | 2118 |
|
|
2021
Q3 | $232K | Buy |
38,000
+1,700
| +5% | +$10.4K | 0.01% | 970 |
|
|
2021
Q2 | $299K | Buy |
36,300
+100
| +0.3% | +$824 | 0.01% | 960 |
|
|
2021
Q1 | $324K | Buy |
36,200
+5,200
| +17% | +$46.5K | 0.01% | 758 |
|
|
2020
Q4 | $358K | Buy |
31,000
+3,600
| +13% | +$41.6K | 0.01% | 462 |
|
|
2020
Q3 | $285K | Sell |
27,400
-600
| -2% | -$6.24K | 0.01% | 405 |
|
|
2020
Q2 | $368K | Buy |
28,000
+25,500
| +1,020% | +$335K | 0.02% | 358 |
|
|
2020
Q1 | $20K | Buy |
+2,500
| New | +$20K | ﹤0.01% | 656 |
|
|
2019
Q3 | – | Sell |
-551
| Closed | -$7K | – | 1745 |
|
|
2019
Q2 | $7K | Buy |
+551
| New | +$7K | ﹤0.01% | 1086 |
|
|
2019
Q1 | – | Sell |
-524
| Closed | -$6K | – | 1885 |
|
|
2018
Q4 | $6K | Buy |
+524
| New | +$6K | ﹤0.01% | 1238 |
|